The largest database of trusted experimental protocols

45 protocols using glucose meter

1

Oral Glucose Tolerance Test in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oral glucose tolerance test (OGTT) was performed within one week before the end of treatment. The mice fasted for 16 h with water and were treated with a glucose meter (Roche, Basel, Switzerland) to determine fasting blood glucose.A 2 g/kg/bw glucose solution was rapidly gavaged, and blood glucose values were measured at 30, 60, 90 and 120 min after gavage [18 (link)]. The area under the OGTT curve (AUC) value was calculated after the glucose value was taken from 0 to 120 min by gavage of glucose.Insulin resistance index (HOMA-IR) was calculated as follows [19 ]: HOMA  IR =FPG × FINS/22.5
In the formula, FPG and FINS represent fasting blood glucose and fasting insulin levels, respectively.
+ Open protocol
+ Expand
2

Wnt5a Inhibitor Effects in Diabetic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-week-old male db/db (C57BLKS/J-leprdb/leprdb) mice and their nondiabetic wild-type littermates (WT) were provided by the Model Animal Research Center of Nanjing University (Nanjing, China). The animals were acclimatized to the laboratory before use. At 8 weeks of age, mice were classified into four groups (n = 8 each): WT + Box5 and db/db+Box5 mice were i.p. injected with the Wnt5a inhibitor, Box5 (1 mg/kg body weight), every other day for 12 weeks from 8 weeks of age; WT + Vehicle and db/db+Vehicle mice received 0.9% physiologic saline on the same schedule as the control mice.
Blood glucose levels and body weight were measured every 2 weeks. Blood glucose levels were determined using a glucose meter (Roche, Basel, Switzerland). Twenty-four-hour urine was collected from mice using metabolic cages every 2 weeks. Urinary albumin and creatinine levels were measured using enzyme-linked immunosorbent assay (ELISA) kits (Abcam, Cambridge, USA). The urine albumin excretion rate was expressed as the ratio of albumin to creatinine. All mice were sacrificed at 20 weeks and blood and tissue samples were harvested. Serum creatinine levels were determined using the QuantiChrom Aassay Kit (BioAssay Systems, Hayward, CA, USA). The animal experiments were approved by the Laboratory Animals Ethical Committee of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital.
+ Open protocol
+ Expand
3

Evaluating Insulin Bioactivity in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the bioactivity of insulin after the production process, the hypoglycemic effect of the released insulin from IPC-NEs or IPC was evaluated in normal rats. Briefly, insulin released from IPC-NEs or IPC at 37°C was collected and the concentration was determined by HPLC. Male Sprague-Dawley (SD) rats (200–250 g) (fasted for 16 hrs with free access to water) were injected subcutaneously with the released insulin or free insulin at a dose of 1 IU/kg (n=6). The blood glucose level was determined using the Roche ACCU-CHEK Go (Basel, Switzerland) glucose-meter at the predesigned time point.
+ Open protocol
+ Expand
4

Metabolic Biomarkers Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood glucose concentration was determined on animals before anesthesia, with a glucose meter (Roche Diagnostic, Meylan, France) on blood collected from the tip of the tail vein. Plasma insulin concentration was determined using ELISA kit (Mercodia, Upssala, Sweden). Homeostasis Model Assessment Insulin Resistance (HOMA-IR) was calculated as follows: [fasted glycemia (mM)*fasted insulinemia (μU/ml)]/22.5. Plasma triglycerides, cholesterol, and non-esterified fatty acids were determined by using commercial kits coupling enzymatic reaction and spectrophotometric detection of reaction in products (DyaSys Diagnostic and Systems, Holzheim, Germany). High density lipoprotein cholesterol (HDL-Cholesterol) concentration was measured enzymatically after very low density lipoprotein (VLDL), chylomicrons and low density lipoprotein cholesterol (LDL-Cholesterol) antibodies precipitation (DyaSys Diagnostic and Systems, Holzheim, Germany). Plasma concentrations of ghrelin, PYY, glucose-dependent insulinotropic polypeptide, (GIP) and glucagon-like peptide-1 (GLP-1) were quantified using a Bio-Plex Multiplex immunoassays kits (Bio-Rad, Nazareth, Belgium) and measured by using Luminex technology (Bio-Plex 200; Bio-Rad) following the manufacturer’s instructions.
+ Open protocol
+ Expand
5

Intraperitoneal Insulin Tolerance Test

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intraperitoneal insulin tolerance test (ipITT) was performed at the end of the HFD treatment period. Rats received glucose solution (2 g/kg of body weight) orally after overnight fasting for 14 h. Then, rats were given an intraperitoneal injection with an insulin (Actrapid, Novo Nordisk Pharmaceutical Co., Denmark) at a dose of 0.75 U/kg of body weight. Blood glucose level was monitored at 0, 15, 30, 45, 60, and 90 min after insulin injection by a glucose meter (Roche, Mannheim, Germany).
+ Open protocol
+ Expand
6

Curcumin and Insulin for Diabetic Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven-week-old male Sprague-Dawley rats, weighing 220–250 g, were purchased from the Animal Experiment Center of Fujian Medical University (Fuzhou, China) and raised in a barrier environment with controlled temperature (20–25°C), humidity (50 ± 5%) and lighting (12 h light/dark cycle). Five groups (n = 12 each) as follows: Group 1: control rats treated with vehicle (CON); Group 2: diabetic model rat (DM); Group 3: diabetic rats treated with curcumin (CUR); Group 4: diabetic rats treated with insulin (INS); Group 5: diabetic rats treated with curcumin and insulin (CUR + INS). Except for the control group, rats from other groups were rendered diabetic by a single intravenous injection of 55 mg/kg streptozotocin (STZ). Three days after STZ injection, fasting blood was collected from the tail vein and measured with a glucose meter (Roche Inc., Basel, Switzerland). Rat with glucose levels >16.7 mmol/L, polyuria, was defined as diabetic and included in the experiments.
+ Open protocol
+ Expand
7

Lipid and Inflammatory Biomarker Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triglycerides and total cholesterol concentrations were determined by enzymatic colorimetric methods using available commercial kits (Wiener lab Group, Argentina). The high-density lipoprotein cholesterol (HDLc) was determined after precipitation of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDLc) with polyanions (dextran sulphate and magnesium chloride). LDL-cholesterol concentration was determined by a two-step homogeneous assay without precipitation. Free fatty acids were determined using available commercial kits (ab65341, Abcam, USA).
Circulating tumor necrosis factor-α (TNF-α) (RAB0479), interleukin-1β (IL-1β) (RAB0277), insulin (RAB0904) (all from SIGMA Aldrich, St. Louis, MO, USA), leptin (ab100773), and adiponectin (ab108784) (Abcam, USA) were performed using commercially available kits according to the manufacturer′s instructions.
Blood glucose concentrations were measured using a glucose meter (Roche Diagnostics GmbH, Mannheim, Germany). The HOMA-IR (Homeostasis model assessment of insulin resistance) index was calculated as [fasting glucose (mg/dl) × fasting insulin (ng/ml)/405] to assess insulin resistance [38 (link)].
+ Open protocol
+ Expand
8

Streptozotocin-Induced Diabetic Rat Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy male rats, 6 weeks old, body mass of 180 ∼ 220 g, purchased from Shanghai SLAC, Ltd (Shanghai, China); Streptozotocin (STZ, Sigma, St. Louis, MO, USA); Glucose meter (Roche, Mannheim, Germany); CD68 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); RAW264.7 cells (Shanghai Bogu Biotechnology Co, Shanghai, China); RPMI-1640 medium (Gibco, Waltham, MA, USA); fetal bovine serum (ScienCell, Carlsbad, CA, USA); Dextrose, mannitol, and Rapamycin (RAPA; Sigma, USA); 3-methyladenine (3-MA) (Sigma, USA); Bafilomycin A1 (BAFA; Abcam, Cambridge, UK); Chloroquine (CQ; Sigma, USA); CD68 (Abcam); LC3 (Sigma, USA); Beclin 1 (Abcam); P62 (Cell Signaling Technology, Danvers, MA, USA); Transwell Chambers (Sigma, USA); and Fibronectin (FN; Cloud Clone, Katy, TX, USA).
+ Open protocol
+ Expand
9

Biochemical Analyses of Renal Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
An automatic biochemical analyzer (7600; Hitachi, Tokyo, Japan) was used to measure blood urine nitrogen and serum creatinine. Renal NF-κB activity was determined with an ELISA kit targeting phosphorylated Ser536 (Abcam, Cambridge, USA). Commercial kits (Nanjing Jiancheng Bio-Engineering Institute, Nanjing, Jiangsu, China) were used to measure MDA and SOD as previously described,14 (link) and the SOD kits detects only Mn-SOD isoforms. Blood glucose levels were determined using a glucose meter (Roche, Basel, Switzerland). Hemoglobin A1c (HbA1c) was measured using an A1cNOW kit (Bayer, Leverkusen, Germany). Fasting plasma insulin concentrations were measured by an ultrasensitive mouse insulin ELISA kit (Mercodia, Uppsala, Sweden). 24-h urine collections were harvested from mice using metabolic cages and then measured with enzyme linked immunosorbent assay (ELISA) kits (Abcam, Cambridge, USA) for the evaluation of urine albumin.
Commercial ELISA kits were used to measure the protein levels of IL-17C, IL-6, and IL-1β in supernatants of HK2 cells under high glucose or hypoxia (IL-17C Elisa kits were purchased from CIGBIO Biomed (Hangzhou, China); IL-6, and IL-1β were purchased from Arigo Biolaboratories, Shanghai, China).
+ Open protocol
+ Expand
10

Metabolic Profile Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All participants were admitted to the health promotion center in the morning after overnight fasting. Data on the demographic and clinical characteristics of the participants were obtained from the medical records or via interviews with the participants. Body mass and height were measured while the participants were wearing a light dress without shoes. The body mass index (BMI) was calculated as weight (kg)/height (m2). Waist circumference (WC) was measured at the narrowest level between the lowest rib and the iliac crest. Hip circumference was measured at the widest portion of the buttocks using a standard tape measure in the standing position. Then, the waist-to-hip ratio was calculated.
Blood samples were drawn after overnight fasting (>12 h) to measure serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels. FBG samples were collected from the cutaneous vein of the fingertip using a puncture device and a glucose meter (Roche, Almere, the Netherlands).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!